By launching Liver Matters, EASL aims to serve the community in a fresh and different way, not structured by scientific tracks or fields of expertise. We’ll be offering you content focused on career and lifestyle, tips and tricks for making it in hepatology, profiles of members of our community sharing their stories, and some behind-the-scenes insights on…
EASL is delighted to announce Digital NAFLD Summit 2021, taking place online 16–17 September 2021. The pandemic has disrupted medical associations, but we’re in full force holding engaging, interactive online events keeping the hepatology community both connected and advancing. Let’s join forces to fight liver disease,…
Multidisciplinary approaches to the health sciences are increasingly in demand – calling on multiple disciplines to tackle diseases from bench to bedside, from R&D through to patient care, often in multidisciplinary tumour boards or centres of excellence. Opportunities to publish this cross-cutting research are also…
EASL is pleased to announce the second round of abstract submissions for ILC 2021. We are calling for companies, scientists, researchers, and investigators to submit regular and high-profile, late-breaker abstracts, 10–27 April 2021.
There is only one week left to take advantage of ILC 2021 early fees! The deadline is Monday, 22 March 23:59 CET. Don't wait for the last minute to save up to EUR 450. Browse the categories to find out what…
EASL’s ILC 2021 will be the 56th iteration of a flagship annual congress – a firmly rooted tradition that is set to be a sparkling, four-day virtual event taking place 23–26 June 2021. Over half a century has passed since the first EASL meeting took place in 1966…
Are you deeply engaged in hepatology and science and ready to get involved in EASL’s governance? EASL is now looking to fill the following positions: EASL Vice-Secretary Three Educational Committee Members Three Policy and Public Health Committee Members Three Young Investigators Task Force Members…
In the wake of the COVID-19 pandemic, several liver associations recommended certain changes in hepatitis clinical care to mitigate transmission risks for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), the causative agent of COVID-19. A follow-up survey was conducted and…
On International Day of Women and Girls in Science, 11 February, EASL honours the many women making waves in our field of hepatology. As highlighted by the UN, both science and gender equality are vital for us to achieve the…
9 February 2021 By end-January 2021, COVID-19, the systemic disease caused by the pandemic spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), accounted for 2.2 million deaths worldwide and for 100 million individuals infected, according to estimates from the…